Ryan Spanheimer – Startup Investor Profile

Engage Venture Partners, led by Ryan Spanheimer, focuses on investing in the medical device, digital health, healthcare information technology (IT), and healthcare software as a service (SaaS) sectors. They prefer seed to Series A stage companies in Minnesota and the Midwest region of the United States. Specific information on geographical preference, previous investments, track record, investment check size, and partnership styles was not found.

Location: Minneapolis, Minnesota

Country: United States of America

Investment Regions:

Investment Stages: pre-seed, seed

Website: https://www.engagevp.com/

AI Reasoning: Engage Venture Partners’ portfolio page shows recent investments involving Ryan Spanheimer: Diatiro – Seed on 6/2024 (approx 16 months before reference date) and Laplace Interventional – Series C on 2/2025 (about 9 months before reference date) and Series B 7/2023; Melodi Health – Series A 5/2023; Agitated Solutions – Series A 11/2023; Pleural Dynamics – Post-Seed Bridge 3/2023; Dosentrx – Seed 12/2022. The most recent known investment is Laplace Interventional Series C in February 2025, which is within 6 to 12 months prior to the reference date; additionally Diatiro in June 2024 is older. February 2025 is less than 6 months prior to November 1, 2025? Wait recalc: February 2025 to November 1, 2025 is 9 months, which places the most recent investment between 6 and 12 months. But portfolio also lists Series B in 7/2023 and Series A for Melodi 5/2023; no investments after Feb 2025 found. Therefore the appropriate tag is ‘active’. However instruction requires returning only the tag in result. Returning ‘very-active’ initially was incorrect; corrected tag: ‘active’.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.